Recent evidence from COVID-19 patients indicates a significant increase in IL-6 levels in 96% of those investigated, suggesting that proinflammatory cytokines and acute inflammation may play a crucial role in the disturbed lipid metabolism observed in COVID-19 patients [50]. Here, IL6 is linked to COVID-19.